
Gemtaz Infusmart 1.4g Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Gemcitabine (1400mg)
Overview Gemtaz Infusmart 1.4g Injection
Oxaliplatin Infusmart 1.4g Injection is indicated for treating several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly via intravenous injection by a healthcare professional. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Always adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, possibly taking weeks or months; discontinue only under medical guidance. Frequent side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can suppress blood cell production, increasing infection risk. Regular blood tests monitoring blood cell counts, cardiac function, hepatic function, and uric acid levels are necessary. Inform your physician of pre-existing heart, liver, or kidney conditions, or current use of anti-infectives, before commencing treatment. Interactions with other medications are possible; disclose all medications to your doctor. Use during pregnancy or breastfeeding is contraindicated. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Gemtaz Infusmart 1.4g Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Gemtaz Infusmart 1.4g Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemtaz Infusmart 1.4g Injection:
Administering this medication will be done by your physician or their associate; self-medication is strongly discouraged.
Common Side effects of Gemtaz Infusmart 1.4g Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemtaz Infusmart 1.4g Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Gemtaz Infusmart 1.4g Injection works:
Gemtaz Infusmart 1.4g Injection disrupts cancer cell proliferation by replacing essential components in their DNA and RNA synthesis. This action halts the growth and replication of malignant cells.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemtaz Infusmart 1.4g Injection and alcohol may result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemtaz Infusmart 1.4g Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Administration of Gemtaz Infusmart 1.4g Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administration of Gemtaz Infusmart 1.4g Injection can induce drowsiness, blurred vision, and dizziness. Driving is discouraged if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemtaz Infusmart 1.4g Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment and post-treatment kidney function assessments are recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Gemtaz Infusmart 1.4g Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Gemtaz Infusmart 1.4g Injection :
NA
Facts to Know About Gemtaz Infusmart 1.4g Injection
| Label | Value |
|---|---|
| Chemical Type | Modified Cytosine |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Metabolic inhibitors |
